Coulter JA - Search Results

1

Cell-Penetrating Peptides as a Tool for the Cellular Uptake of a Genetically Modified Nitroreductase for use in Directed Enzyme Prodrug Therapy.

Anderson SD, Hobbs RJ, Gwenin VV, Ball P, Bennie LA, Coulter JA, Gwenin CD. Anderson SD, et al. Among authors: coulter ja. J Funct Biomater. 2019 Oct 1;10(4):45. doi: 10.3390/jfb10040045. J Funct Biomater. 2019. PMID: 31581475 Free PMC article.

2

Enhanced nanoparticle delivery exploiting tumour-responsive formulations.

Bennie LA, McCarthy HO, Coulter JA. Bennie LA, et al. Among authors: coulter ja. Cancer Nanotechnol. 2018;9(1):10. doi: 10.1186/s12645-018-0044-6. Epub 2018 Nov 21. Cancer Nanotechnol. 2018. PMID: 30595759 Free PMC article. Review.

3

Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme.

Jena LN, Bennie LA, McErlean EM, Pentlavalli S, Glass K, Burrows JF, Kett VL, Buckley NE, Coulter JA, Dunne NJ, McCarthy HO. Jena LN, et al. Among authors: coulter ja. J Nanobiotechnology. 2021 May 4;19(1):127. doi: 10.1186/s12951-021-00856-x. J Nanobiotechnology. 2021. PMID: 33947409 Free PMC article.

4

Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment.

Bennie LA, Feng J, Emmerson C, Hyland WB, Matchett KB, McCarthy HO, Coulter JA. Bennie LA, et al. Among authors: coulter ja. J Nanobiotechnology. 2021 Sep 19;19(1):279. doi: 10.1186/s12951-021-01019-8. J Nanobiotechnology. 2021. PMID: 34538237 Free PMC article.

5

Gold nanoparticle cellular uptake, toxicity and radiosensitisation in hypoxic conditions.

Jain S, Coulter JA, Butterworth KT, Hounsell AR, McMahon SJ, Hyland WB, Muir MF, Dickson GR, Prise KM, Currell FJ, Hirst DG, O'Sullivan JM. Jain S, et al. Among authors: coulter ja. Radiother Oncol. 2014 Feb;110(2):342-7. doi: 10.1016/j.radonc.2013.12.013. Epub 2014 Jan 17. Radiother Oncol. 2014. PMID: 24444528

6

Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles.

Coulter JA, Jain S, Butterworth KT, Taggart LE, Dickson GR, McMahon SJ, Hyland WB, Muir MF, Trainor C, Hounsell AR, O'Sullivan JM, Schettino G, Currell FJ, Hirst DG, Prise KM. Coulter JA, et al. Int J Nanomedicine. 2012;7:2673-85. doi: 10.2147/IJN.S31751. Epub 2012 Jun 1. Int J Nanomedicine. 2012. PMID: 22701316 Free PMC article.

7

Octaarginine-modified gold nanoparticles enhance the radiosensitivity of human colorectal cancer cell line LS180 to megavoltage radiation.

Zhang X, Wang H, Coulter JA, Yang R. Zhang X, et al. Among authors: coulter ja. Int J Nanomedicine. 2018 Jun 19;13:3541-3552. doi: 10.2147/IJN.S161157. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29950834 Free PMC article.

8

Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.

McCarthy HO, Coulter JA, Worthington J, Robson T, Hirst DG. McCarthy HO, et al. Among authors: coulter ja. J Gene Med. 2007 Jun;9(6):511-20. doi: 10.1002/jgm.1045. J Gene Med. 2007. PMID: 17471586

9

The radiation-inducible pE9 promoter driving inducible nitric oxide synthase radiosensitizes hypoxic tumour cells to radiation.

Coulter JA, McCarthy HO, Worthington J, Robson T, Scott S, Hirst DG. Coulter JA, et al. Gene Ther. 2008 Apr;15(7):495-503. doi: 10.1038/gt.2008.7. Epub 2008 Feb 7. Gene Ther. 2008. PMID: 18256696

10

Nitric oxide--a novel therapeutic for cancer.

Coulter JA, McCarthy HO, Xiang J, Roedl W, Wagner E, Robson T, Hirst DG. Coulter JA, et al. Nitric Oxide. 2008 Sep;19(2):192-8. doi: 10.1016/j.niox.2008.04.023. Epub 2008 Apr 29. Nitric Oxide. 2008. PMID: 18485922 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page